In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells
Brazilian Journal of Pharmaceutical Sciences - Brazil
doi 10.1590/s2175-97902019000318254
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
FapUNIFESP (SciELO)